Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Roger Corbett Insider Profile
4 Followers
Roger Corbett, Director at Mayne Pharma Group, holds 10.44M shares in Mayne Pharma Group (Ticker: MAYNF). Most recently, Roger Corbett Bought $155,800 shares of Mayne Pharma Group on Dec 19, 2016 for an estimated value of 199.92K.
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-16.30%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Roger Corbett holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Feb 23, 2015 - Feb 23, 2016
Return:+35.80%
The most profitable trade made by Roger Corbett
Roger Corbett's Trading History
List of latest transactions for each holding click on a transaction to see Roger Corbett's performance on stock
You May Also Like
Roger Corbett insider profile FAQ
What is the percentage of profitable transactions made by Roger Corbett?
The percentage of profitable transactions made by Roger Corbett is 33%.
What is the average return per transaction made by Roger Corbett?
The average return per transaction made by Roger Corbett is -16.30%.
What stocks does Roger Corbett hold?
Roger Corbett holds: MAYNF stocks.
What was Roger Corbett’s latest transaction?
Roger Corbett latest transaction was an Informative Buy of $199.92K.
What was Roger Corbett's most profitable transaction?
Roger Corbett’s most profitable transaction was an Informative Buy of MAYNF stock on February 23, 2015. The return on the trade was 35.80%.
What is Roger Corbett's role in Mayne Pharma Group?
Roger Corbett's role in Mayne Pharma Group is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.